Recursion Pharmaceuticals
RXRX
#3930
Rank
S$3.30 B
Marketcap
$8.46
Share price
-12.71%
Change (1 day)
-32.83%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - P/B ratio

P/B ratio as of December 2024 : 4.63

According to Recursion Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 37.5898.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Recursion Pharmaceuticals - P/B ratio (from 2021 to 2024)

20222023202446810companiesmarketcap.com

P/B ratio by year

Year P/B ratio Change
2024-12-315.5921.68%
2023-12-314.5952.67%
2022-12-313.01-43.58%
2021-12-315.33
2020-12-31N/A